Clinical Trials in Detroit

Showing 10121-10140 of 19,719 trials

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

NCT00000888

The purpose of this study is to see if it is safe and effective to give ritonavir (RTV) plus lamivudine (3TC) plus zidovudine (ZDV) to HIV-infected pregnant women during pregnancy and to their babies after birth. Pregnant women who are HIV-positive are at risk of giving HIV to their babies during pregnancy or delivery. It is important to learn how to prevent HIV-positive pregnant women from giving HIV to their babies. RTV and ZDV have been shown to be safe and effective against HIV in adults. The combination of 3 anti-HIV drugs (RTV, 3TC, and ZDV) may help prevent HIV infection from mother to infant but studies are needed to determine whether they are safe and effective during pregnancy.

HIV InfectionsPregnancy

National Institute of Allergy and Infectious Diseases (NIAID)14 participants

Miami, Florida, United States • Miami, Florida, United States • Detroit, Michigan, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

NCT00865969

The purpose of this study is to assess efficacy and safety of belinostat in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL), who failed at least one prior systemic therapy.

Peripheral T-cell Lymphoma

Spectrum Pharmaceuticals, Inc129 participantsStarted Dec 2008

Duarte, California, United States • La Verne, California, United States • Palm Springs, California, United States +114 more locations

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

Find Trials by Condition in Detroit

Longitudinal Performance of Epi proColon

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Cocaine Use Reduction With Buprenorphine

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)

Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women